We developed a model of spontaneously high human remn hypertensron m the rat by producing two transgemc strains, one for human angrotensmogen with the endogenous promoter and one for human renm with the endogenous promoter Neither transgemc strain was hypertensive These strains were then crossed, producing a double transgemc strain The double transgemc rats, both males and females, developed severe hypertension (mean systolic pressure, 200 mm Hg) and died after a mean of 55 days If untreated The rats had a human plasma rerun concentratton of 2692381 (+SD) ng angtotensm I (Ang I)/mL per hour, plasma renm actrvrty of 1772176 ng Ang I/mL per hour, rat angtotensmogen concentratron of 1 492 1 pg Ang I/mL, and human angtotensmogen concentration of 78239 pg Ang I/mL (n=49) Control rats had plasma remn actrvrty of 3 7t3.9 ng Ang I/mL per hour and rat angrotensmogen of 1 3220 16 /lg Ang I/mL Angrotensmogen transgene expression by RNase protectton assay was ubrqmtously present but most prominent m liver Renm transgene expression was htgh m kidney but absent m liver The rats featured severe cardiac hypertrophy, with mcreased cross section of cardromyocytes but little myocardtal fibrosts The kidneys showed atrophrc tubules, thickened vessel walls, and increased mterstttmm Both the angtotensm-converting enzyme mhtbttor hsmopnl and the specific human remn mhtbttor remrkrren lowered blood pressure to normal values Double transgemc mice have been developed that exhibit features quite similar to those described here, their gene expressions are stmtlar The spectfictty of rodent and human renm 1s stmrlarly documented Although many elegant physrologtcal studtes can now be done m mice, rats nevertheless offer flexrbdrty, partrcularly m terms of detailed cardiac and renal phystology and pharmacology We conclude that this double transgemc strain wtll facthtate srmultaneous mvesttgatton of genettc and pathophystologtcal aspects of remn-induced hypertension The fact that human renm can be studied m the rat IS a unique feature of this model (Hypertensron. 1997 When infused wrth hREN, this otherwrse normotensrve rat becomes severely hypertensive 1 Under the condrtton of chronic mfusron wrth hREN, the rat is smtable for study of hREN mhtbitors, whrch otherwrse have no effect in the rat.2 However, for study of the human renm-angrotensm system m the rat for perrods ranging from weeks to months, the mimpump mfuston model has maJor shortcommgs, making rt not suitable for studying mechanisms of cardiac hypertrophy, hypertensive nephrosclerosrs, or central nervous system damage To ctrcumvent this problem, we have crossed the TGR(hAOGEN) with a TGR harboring the hREN gene. This TGR(hREN)IOJ was developed m Japan In- Correspondence to Frredrrch C Luft, Franz Volhard Clnuc, Wrltberg Strasse 50, 13122 Berlin, FRG E-marl fcluft@ orton rz mdc-berlm de 0 1997 Amerrcan Heart Assocratron, Inc formation on this rat has not yet been published Offspring from this cross harbor both transgenes and therefore have all the necessary components of the human rerun-angtotensm system for generation of Ang II We measured components of the rat and human remn-angrotensm system m these rats, we studied the expression of both transgenes, we observed blood pressure and endorgan damage; we determined survival, and we tested an orally effective hREN mhrbrtor We conclude that this TGR (hAOGEN-hREN) and nontransgemc Sprague-Dawley rats wetghmg 230 to 350 g were used for the experiments The transgemc lme and Its characteristics have been described elsewhere 1-3 Briefly, TGR(hAOGEN) show high hAOGEN gene expression m the hver, kidney, heart, aorta, brain, and adrenal glands Then plasma hAOGEN concentrations exceed endogenous AOGEN concentrations by 50-to loo-fold A new TGR carrying the entire hREN gene DNA with 10 exons and 9 mtrons spanning 15 kb mcludmg 3 kb of Its 5' flanking promoter region and a 1 2-kb 3' flanking region was created by oozyte mmromJectron methods on outbred SpragueDawley background, as published elsewhere.5 A homozygous line, TGR(hREN)lOJ, was established from a male founder rat with appropriate backcrosses The TGR were normotensrve All 
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Animals

Methods
Male Sprague-Dawley rats homozygous for the complete human genomtc angtotensmogen gene [TGR(hAOGEN)1623] and nontransgemc Sprague-Dawley rats wetghmg 230 to 350 g were used for the experiments The transgemc lme and Its characteristics have been described elsewhere 1-3 Briefly, TGR(hAOGEN) show high hAOGEN gene expression m the hver, kidney, heart, aorta, brain, and adrenal glands Then plasma hAOGEN concentrations exceed endogenous AOGEN concentrations by 50-to loo-fold A new TGR carrying the entire hREN gene DNA with 10 exons and 9 mtrons spanning 15 kb mcludmg 3 kb of Its 5' flanking promoter region and a 1 2-kb 3' flanking region was created by oozyte mmromJectron methods on outbred SpragueDawley background, as published elsewhere.5 A homozygous line, TGR(hREN)lOJ, was established from a male founder rat with appropriate backcrosses The TGR were normotensrve All Selected Abbreviations and Acronyms Ang I, II = angrotensm I, II AOGEN = angtotensmogen h = human PRA = plasma remn actrvtty PRC = plasma renm concentratron r = rat REN = remn TGR = transgemc rat rats were kept under standard condrtrons at 2422°C fed a commercial rat chow (No C-1000, Altromm) contammg 0 2% sodium by weight, and had free access to tap water Six male homozygous TGR(hAOGEN) were mated wrth two female homozygous TGR(hREN) each Thirty-tom male and 1.5 female offsprmg heterozygous for both transgenes were obtained The presence of the two transgenes was checked by Southern blotting * Drmkmg water was measured dally and body weight determined twice a week When signs of illness were observed, rats were killed by an overdose of mtraperttoneal ketamme with xylazme, and organs were removed Blood pressure was measured by the tall-cuff method with rats under light ether anesthesta The wet wetght (grams) of the hearts was determined Nine male and 3 female age-matched Sprague-Dawley rats were used as controls and killed m parallel with the double TGR Stx female double TGR received the angrotensm-convertmg enzyme mhrbrtor hsmoprtl (10 mg/L) for 7 days m their drmkmg water Srx female double TGR received the hREN mhtbrtor remrknen" (100 mg/L) m drmkmg water (Ro 42-5892, Hoffmann-La Roche) The remtktren concentratton was chosen on the basis of the broavatlability of the compound Blood samples (0 6 mL) were drawn by Jugular venous puncture before and at the end of experiments 01 at the time of death For this purpose, the rats were anesthetrzed with ketarmne-xylazme (15 and 5 mg/kg body wt IP) Antrcoagulatton was with Na*EDTA (6 25X 10mh mol/mL of blood) hAOGEN and rAOGEN concentratrons, total PRA, human-and rat-specrfic PRCs (hPRC and rPRC), and human plasma prorenm concentratrons were determined by enzyme-kinetic assay For a detailed analysis of gene expression, 13 organs from one TGR(hREN) and one double TGR were removed, snap-frozen m hqmd nitrogen, and stored at -70°C Tissue was also processed m formahn for hrstology PRA, hPRC, rPRC, rAOGEN, and hAOGEN were measured by m vitro enzyme-kmettc assays specrfically developed and validated for this purpose r 7 * PRA was determined at pH 7 4 hPRC &Mender et al Human Renin Hypertension in Rats 429 was determined at pH 5 7 and rPRC at pH 6 3 To provide excess homologous substrate durmg hPRC determmatrons, pooled plasma from 48-hour bilaterally nephrectomrzed TGR(hAOGEN)I623 was used contammg 264 nmol/mL hAOGEN A plasma pool from 48-hour nephrectomtzed Sprague-Dawley rats contammg 4 4 nmol/mL rAOGEN was used dunng determmatrons of rPRC Both pools had been checked for the absence of residual PRA Human plasma proremn concentrations were determmed by a similar protocol. First, 100 PL plasma was treated with 0 1 mg bovine trypsm (200 IU/mg, Worthington No 3744) at 4°C to activate all plasma proremn to rerun The reaction was stopped after 90 minutes by addition of soybean trypsm mhtbttor (Serva) to the mcubatton mixture at a concentratton of 2 U per umt trypsm Total PRC was then assayed as tor hPRC Human plasma prorenm concentratton was calculated as the difference between hPRC and total rerun concentratron. All m vitro mcubattons were repeated in the presence of remtktren (2 5X 10m7 mol/L) to control for species spectfictty of the Ang I-forming pathway
The Ang I generated during the various m vitro mcubattons was measured by direct radtotmmunoassay 3 Acttvtttes and concentrations are expressed as nanograms Ang I per mrlhhter per hour or micrograms Ang I per mtlhhter, as necessary All radroimmunoassay determmattons were done m trtphcate Measurements were made at two different concentrations Remtkuen or hsmoprtl dtd not interfere with measurements The senctttvtty of the radtoimmunoassay as defined by the concentratron of Ang I capable of dtsplacmg the '251-labeled Ang I tracer by 20% was 3 to 4 pg per assay tube A displacement of 50% of the tracer was achieved at a concentratron of 2124 pg per tube (n=l 1) The mean mtra-assay and mterassay vanabrhtres were 9% and 13%. respectively
RNase Protection Assay
Total RNA was isolated from snap-frozen ttssues by a standard hthmm chlortde/urea precrpttatron technique 9 mRNAs specific for hAOGEN, rAOGEN, rat and hREN, and /?-actm were then tdentrfied by RNase protectton assay with an Ambton RPA III ktt (ITC Biotechnology GmbH) according to protocols suggested by the manufactmer Anttsense RNA probes were prepared by T7 polymerase transcnphon with cDNA fragments specthc for hAOGEN and tAOGEN subcloned mto pGEM5 and pGEM4 vectors as well as cDNA fragments specific for rREN, hREN, and rat P-actm subcloned mto pGEM4 and pBluescrtpt SK II+ vectors, respectively, as described previously 14 The protected sequences of the various probes were 132, 290, 297, 225, and 150 nucleotides m the above given order All probes were radtolabeled with [32P]UTP to a specrfic acttvrty of greater than 2X 10' cpm/pg RNA. Ten micrograms total RNA was hybridized for the remn blots and 1 pg total RNA for the AOGEN blots, with a minimum of 1 .SX 10' cpm of specific antisense probe, and cohybridized with a similar excess of ,/3-actin-specific antisense RNA serving as an internal control. Probe fragments subsequently protected from combined RNase A/T1 digestion were separated by electrophoresi5 on a 5% denaturing polyacrylamide gel and viFualised with a FUJIX BAS 2000 Phospholmager system after 8 hours of autoradiography.
Histology
For conventlonal morphology, the heart and right kidney were removed and cut sagitally, and the tissue was fixed in 4% phosphate-buffered paraformaldehyde at room temperature. Subsequently, the tissue was dehydrated and embedded in paraffin. Sections 2 to 3 pm thick were cut with a microtome (LeltL 1512). The sections were then deparafliniLed and rehydrated before staining with hematoxylin and eosin and periodic acid-Schiff for morphological examination. 1"
Statistical Methods
Mean values with SD and linear regression parameters were calculated. Frequency distribution5 were tested by the Kolmogorov-Smlrnov test. Differences between contrasting groups wcrc tc\tcd cithcr by one-way ANOVA or by Student's f test using StatView software on a Macintosh computer. A value of P<.OS was regarded as significant. The terms increased and decreased are used only when significant.
Results
Data from heterozygous TGR(hREN) before and after 14 days of lisinopril treatment are given in the Table. rPRC and hPRC both increased dramatically with lisinopril more than lo-fold. We also measured human prorenin, which did not change significantly. These data indicate that the transgene of the heterozygous TGR(hREN) responds promptly and appropriately to angiotensin-converting enzyme inhibition. The double TGR values are also shown in the Table. The measurements were obtained at death and are without any treatment. hPRC was substantially higher, nearly lo-fold, in the double TGR than in the TGR(hREN). PRA was 30-to .50-fold higher than in nontransgenic control rats. There was no significant difference between male and female TGR. A linear correlation between PRA and hPRC (r=.94, P<.O5) was observed. hAOGEN values were elevated to a degree similar to that in TGR(hAOGEN).lJ Plasma hAOGEN concentrations and systolic pressure (r=.35, P=.O5) were correlated in our rats, although the correlation was not robust. The rAOGEN values were similar to those of nontransgenic control rats. 
Blood pressure values are shown in Fig 1 (top) . The rats averaged 7 weeks of age at the time of measurement. The systolic values approached 200 mm Hg and were 80 mm Hg higher than those in control rats. There was no significant blood pressure difference between male and female double TGR. Since we euthanized the rats dependent upon their condition, we are able to comment on their survival. The youngest double TGR was euthanized 50 pm. at 29 days, the oldest at 81 days (mean, 55tlO). Nine rats were found dead and were not included in the study. Unfortunately, we were not able to determine a histological cause of death. No evidence of stroke was found. The hearts of double TGR averaged 0.56kO.06 g/100 g body wt, and that of control rats averaged 0.31-~0.02 g/100 g body wt (P<.O5). The left ventricles were visibly enlarged. At 8 weeks, the body weights of double TGR averaged 218233 g for males and 160215 g for females, which was not significantly different from weights of control rats. Double TGR drank 61 -C 12 mL/d, and control rats drank 3227 mL/d (P<.O5) . Fig 1 (bottom) shows a quantification of cardiomyocyte diameter. Frequency distributions of double TGR and control rats are shown (n=7); they were significantly different. The mean diameter of double TGR muscle cells was about 20% wider than that of control cells. Histological sections from kidneys are shown in Fig 2 . The glomeruli were preserved (Fig 2a and 2b) ; however, the vessels showed increased intimal and medial thickness, the tubules were frequently filled with proteinaceous material, and the interstitium showed moderate infiltration. The control section (Fig 2c) did not show these changes. Fig 3 shows a section from a normal heart ( Fig  3A) and one from a double TGR heart (Fig 3B) . The
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Vol 29, No 1, Part 2 January 1997 individual cardiomyocytes were visibly larger in cross section in double TGR. Remarkably little interstitial fibrosis was present. Fig 4A shows an RNase protection assay of 13 different tissues for hREN gene expression in a heterozygous TGR(hREN). Expression was detected in aorta, adrenal gland, ovary, skeletal muscle, spleen, kidney, and lung. None was found in brain or liver under these conditions. The double TGR (Fig 4B) showed rREN and hREN. rREN was found in kidney, with a trace in the adrenal gland. hREN was found in the same tissues as in the heterozygous rat. rAOGEN (Fig 4C) was found in liver, brain, and cerebellum. hAOGEN (Fig 4C) was found in all organs at different levels. The liver and kidney showed the highest values.
Lisinopril administration in six double TGR decreased blood pressure from 191?25 mm Hg on day 0 to 129+7 mm Hg by day 7 (P<.O5). Remikiren decreased blood pressure from 190t24 mm Hg on day 0 to 124216 mm Hg by day 7 (n=6, P<.O5). The blood pressure decreases were not different for the two compounds.
Discussion
The important findings in this study were that a TGR-(hAOGEN) and TGR(hREN) cross produced offspring with chronic, severe, high hREN hypertension in the rat. Blood pressure values were markedly elevated, severe cardiac hypertrophy resulted, the kidneys developed nephrosclerosis even with both organs in place, and the rats died untreated after about 8 weeks. Circulating hPRC and hAOGEN were detected at high levels, although there was considerable variability in the values, which appeared to be greater than the variability in blood pressure. The hAOGEN transgene was expressed in all tissues tested but was highest in the liver. The hREN transgene was present in kidney but not in liver. An hREN inhibitor and an angiotensin-converting enzyme inhibitor both reduced the blood pressure to normal values, documenting the mechanism of the blood pressure elevation.
Ours is not the first double transgenic model of high hREN hypertension. Fukamizu et alli developed double transgenic mice harboring both the hAOGEN and hREN genes. They were able to demonstrate a sustained increase in blood pressure in crossmated separate lines and showed that the hypertension in the hybrid mice was initiated by the interaction between the products of the two human genes. They proved their point by lowering blood pressure in hypertensive mice with an angiotensinconverting enzyme inhibitor, a Ang II receptor blocker, and an hREN-specific renin inhibitor similar to the one we used. Merrill et alI2 also generated transgenic mice harboring both the hAOGEN and hREN genes. hPRA and Ang II levels were both elevated in their model, and the mice were hypertensive with mean systolic values of 170 mm Hg. The authors observed a resetting of the baroreflex, without alterations in baroreflex sensitivity. Our double transgenic rats are understandably quite similar to the double transgenic mice of Fukamizu et al and Merrill et al. They observed hREN and hAOGEN transgene expression in the kidneys, whereas only hAOGEN was expressed in liver. We observed similar transgene expresqion in the rat.
Our experiment demonstrates once again the species specificity of the renin-angiotensin system. Expressron was detected in aorta (AO), adrenal gland (AG), ovary (OV), skeletal muscle (MU), spleen (SP), kidney (KI), and lung (LU). None was found In brain (BN) or liver (LI) under these conditions.
The double TGR (B) showed rREN and hREN. rREN was found in kidney and ovary, with a trace in the adrenal gland. hREN was found in the same tissues as in the heterozygous rat. rAOGEN (C) was found in liver, brarn, and cerebellum (GE). hAOGEN (C) was found in all organs at different levels. The liver and kidney showed the highest values. PS indicates pancreas; IL, ileum; TS, thymus;
HT, heart; SM, submaxillary gland; P, assay probe; and NT, nontransgenic.
by guest on June 26, 2017 http://hyper.ahajournals.org/ Downloaded from not proteolytlcally cleave rat rAOGEN effectively and nelther does rREN cleave hAOGEN Thus, both parental transgemc lmes were normotenslve The TGR(hREN) had higher hPRC than rPRC values and, mterestmgly, had substantial levels of human prorenm hPRC and rPRC both increased slgmficantly after lismopnl, indicating that the hREN transgene 1s physlologlcally regulated In the double transgemc cross, the hPRC values were slmllar to those m the parental strain, despite the elevated blood pressure. The hAOGEN values were somewhat lower than those we reported earher for the parental stram 1 These measurements vaned substantially, and refinements m breeding of subsequent lmes will be necessary We observed a significant correlation between hAOGEN and systolic pressure m the double TGR cross but could find none between hREN and blood pressure
The transgene expressions we observed m our double TGR cross were similar to those reported earlier for m~c=$.12 I6 17. , namely, hREN was expressed predomlnantly m the kidney and hAOGEN was most prominent m liver, although m our study we found hAOGEN to be widely distributed The dlstrlbutlon of the transgenes 1s consistent with the promoters used For hREN, the entire gene was used, including rts own promoter region In the case of hAOGEN, the endogenous promoter was also used, explammg the high expression m liver tlssue 2 The hREN expression 1s different from the rREN expression described by Ohkubo et al,18 who found the rat transgene to be predommantly expressed m the liver of transgemc mice They used transgenes conslstmg of a fusion between the metallothlonem promoter and the coding region of either rerun or anglotensmogen This approach resulted in unregulated expression of rREN and rAOGEN mRNA m the liver, the major site of metallothlonem promoter actlvlty In their study, Ohkubo et al found that mice harboring the rREN gene became severely hypertensive We observed earlier that rats harbormg a mouse remn (mREN2) gene also became severely hypertensive '7 Furthermore, mice carrying the rAOGEN gene are hypertensive as well I9
In the present study, we examined the hearts and kidneys morphologically The hearts of rats carrying both transgenes were remarkably hypertrophled, which we were able to document not only with organ weight but also by quantitative measurement of the cardlomyocytes. Both pressure overload and Ang II acting directly serve to mcrease left ventricular mass 20,21 Susie et a122 recently showed that Ang II increases left ventricular mass wlthout affecting myosm lsoform mRNAs. We also found that vascular disease and nephrosclerosls were present m our rats. Ang II has been shown to promote intercellular adhesion molecule-l and collagen expression 23.24 Furthermore, Ang II also leads to transforming growth factor-p gene expression 25 The double transgemc strain we have developed will faclhtate research on the mechanisms of cardiac and renal damage secondary to pressure overload as well as Ang II-dependent mechanisms Although many physlologlcal observations can now be conducted m mice, rats still have the advantage of size, permitting more detailed assessments of renal and cardiac functions We have reported a transgemc rat model in which lifelong overexpresslon of both hREN and hAOGEN lead to severe, sustained hypertension with end-organ, notably cardiac and renal, damage The model 1s unique in that it will allow study of Ang II-related mechanisms m a system that can easily be evaluated physlologlcally. Genetic and physlologlcal mampulatlons can be conducted simultaneously Moreover, the model relies on human renm-anglotensm system components Thus, certain pharmacological mvestlgatlons of species-specific agents such as hREN inhibitors become possible m a rat model. We have presented prellmmary data documenting this feature
